Table 2.
Summary of results
| Cerebellum | PFC | |
|---|---|---|
| Total extractable Gs | NS | ↓ Suicide |
| TX-100 soluble (TX-100) | NS | ↓ Suicide |
| TX-100 resistant (TX-114) | NS | ↓ Suicide |
| ANCOVA (PMI, pH, age) TX-100 | — | No effect |
| ANCOVA (PMI, pH, age) TX-114 | — | No effect |
| ANCOVA (AD) TX-100 | No effect | No effect |
| ANCOVA (AD) TX-114 | No effect | No effect |
| ANCOVA (drug) TX-100 | — | No effect |
| ANCOVA (drug) TX-114 | — | No effect |
| TX-100/TX-114 Ratio | ↓ Suicide | ↓ Suicide |
| ANCOVA (PMI, pH, age) TX-100/TX-114 | No effect | No effect |
| ANCOVA (AD) TX-100/TX-114 | No effect | No effect |
| ANCOVA (drug) TX-100/TX-114 | No effect | No effect |
NS, No significant difference between control and suicide subjects; ↓Suicide, significant decrease in the suicide subjects compared with control; —, not measured; ANCOVA, analysis of confounding variables (in parentheses) was used when there was a significant difference between values measured and when antidepressants were found in the subjects at the time of death; no effect, analysis of the data with the confounding variable had no effect on the original analysis.